生物钟Bmal1基因与肿瘤治疗的研究进展及未来新思路

陈越; 金风

doi:10.3969/j.issn.1000-8179.2019.10.366

生物钟Bmal1基因与肿瘤治疗的研究进展及未来新思路

doi: 10.3969/j.issn.1000-8179.2019.10.366

陈越^{①, ②,},
金风^②, ,

①.
贵州医科大学（贵阳市550000）
②.
贵州医科大学附属肿瘤医院，贵州省肿瘤医院头颈肿瘤科

基金项目:

国家自然科学基金项目 81560437

详细信息

作者简介:
陈越专业方向为头颈肿瘤的诊治与研究。E-mail：chenyue5280@yeah.net

通讯作者:
金风 jinf8865@yeah.net

计量
- 文章访问数: 83
- HTML全文浏览量: 49
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2019-04-01
- 修回日期: 2019-05-15
- 刊出日期: 2019-05-30

Research progress and new ideas in circadian gene Bmal1 and oncotherapy

Chen Yue^{①, ②
,},
Jin Feng^{②
, ,}

①.
Guizhou Medical University, Guiyang 550000, China
②.
Department of Head and Neck Oncology, Cancer Hospital of Guizhou Medical University, Guiyang 550000, China

Funds:

National Natural Science Foundation of China 81560437

More Information

Corresponding author: Jin Feng; E-mail: jinf8865@yeah.net

摘要

摘要: 昼夜节律参与调节生物体的生命活动，使生物的生理活动呈周期性、有序性和协同性。Bmall1基因为昼夜节律体系的核心元件之一，在肿瘤组织和正常组织中存在不同程度的表达。Bmal1基因在不同的肿瘤中作用各异。因此，分析Bmal1在不同肿瘤发生过程中的作用能为临床早期发现和有效治疗肿瘤提供新的理论依据。近年来，随着时间医学的深入研究，依照人体生物节律与药代动力学相结合的时辰化疗已成为治疗肿瘤的重要方法。不同时间放疗会导致不同的放射敏感性，使得时辰放疗在肿瘤治疗中的地位日益突出。深入研究生物的昼夜节律性，能为肿瘤的治疗开启全新的视角。
- 昼夜节律 /
- Bmal1基因 /
- 肿瘤 /
- 时辰治疗
Abstract: Circadian rhythm plays a role in regulating life activities and contributes to periodicity, orderliness, and synergy in organisms. The Bmal1 gene is one of the core components of the circadian rhythm system; the level of Bmal1 expression differs between tumor and normal tissues. Studies have shown that Bmal1 plays different roles in different tumors. Therefore, understanding the role of Bmal1 in different tumorigenesis could provide a new theoretical basis for early detection or effective treatment of tumors. In recent years, with the in- depth studies on time- based approaches, chrono- chemotherapy, which combines pharmacokinetics and biotic rhythm, has become one of the important methods of tumor treatment. Radiotherapy at different times can lead to differences in radiosensitivity, which makes chrono-radiotherapy increasingly prominent in tumor treatment. In-depth studies on circadian rhythm in cancer biology could provide new perspectives for tumor treatment.
- circadian rhythm /
- Bmal1 gene /
- tumor /
- chrono-therapy

HTML全文

参考文献(44)

[1]	King DP, Takaheshi JS. Molecular genetics of circadian rhythms in mammals[J]. Annu Rev Neurosci, 2000, 23(7):713-742 doi: 10.1146-annurev.ne.18.030195.002531/
[2]	黄诗颖, 吴伟莉, 金风.恶性肿瘤时辰化疗临床运用研究进展[J].肿瘤预防与治疗, 2014, 27(6):280-284. doi: 10.3969/j.issn.1674-0904.2014.06.006
[3]	Juan X, Guangming L, Hospital NC, et al. Research advances of circadian clock genes and chronnotherapy[J]. Modern Oncology, 2013, 21(11): 2622-2625. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=sxzlyx201311074
[4]	谢丽, 胡文静, 刘宝瑞.肿瘤起源及未来肿瘤治疗[J].中华肿瘤杂志, 2018, 40(2):81-84. doi: 10.3760/cma.j.issn.0253-3766.2018.02.001
[5]	Hardin PE. Molecular genetic analysis of circadian timekeeping in drosophila[J]. Adv Genet, 2011, 74(5):141-173. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1177/074873001129002015
[6]	瞿波, 金风.昼夜节律基因BMAL1在肿瘤中的研究进展[J].肿瘤预防与治疗, 2016, 3(9):171-175. http://d.old.wanfangdata.com.cn/Periodical/sczlfz201603009
[7]	Lee Y, Chun SK, Kim K, et al. Sumoylation controls clock-bmal1-me-diated clock resetting via CBP recruitment in nuclear transcriptional foci[J]. Biochim Biophys Acta, 2015, 1853(10Part A):2697-2708. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=f7f5942aef29c6d62cd3b8ac21ec3b01
[8]	Ye R, Selby CP, Chiou YY, et al. Dual modes of clock: bmal1 inhibition mediated by crytochrome and period proteins in the mammalian circadian clock[J]. Genes Dev, 2014, 28(18):1989-1998. doi: 10.1101/gad.249417.114
[9]	Tan XC, Zhang P, Zhou L, et al. Clock-controlled mir-142-3p can target its activator bmal1[J]. BMC Mol Biol, 2012, 13(248):27-35. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_d69e43f1a8c3374a6bfb41ff8fe239fa
[10]	Jung CH, Kim EM, Park JK, et al. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3- kinase- Akt- MMP- 2 signaling pathway[J]. Oncol Rep, 2013, 29(6): 2019-2113. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=1f38e3683a841e4cf8cd90e021cda985
[11]	Hsu CM, Lin SF, Lu CT, et al. Altered expression of circadian clock genes in head and neck squamous cell carcinoma[J]. Tumour Biol, 2012, 33 (1):149-155. doi: 10.1007/s13277-011-0258-2
[12]	He QY, Jin F, Li YY, et al. Prognostic signficance of downregulated BMAL1 and upregulated Ki- 67 proteins in nasopharyngeal carcinoma[J]. Chronobiol Int, 2018, 35(3):348-357. doi: 10.1080/07420528.2017.1406494
[13]	Tang Q, Cheng B, Xie M, et al. Circadian clock gene Bmal1 ingibits tumorigenesis and increases paclitaxel sensitivity in tongue squamous cell carcinoma[J]. Cancer Res, 2017, 77(2):532-544. http://cn.bing.com/academic/profile?id=f5baa84594c3578243748d83e2c48c57&encoded=0&v=paper_preview&mkt=zh-cn
[14]	Jung CH, Kim EM. Bmal1 suppresses cancer cell invasion by blocking the phosphonositide 3-kinase-Akt-MMP-2 signaling pathway[J]. Oncol Rep, 2013, 9(6):2109-2113. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM23563360
[15]	Zeng ZL, Wu MW, Sun J, et al. Effects of the biological clock gene bmal1 on tumour growth and anti-cancer drug activity[J]. J Biochem, 2010, 148(3):319-326. doi: 10.1093/jb/mvq069
[16]	Sakamoto W, Takenoshital S. Overexpression of both clock and bmal1 inhibits entry to s phase in human colon cancer cells[J]. Fukushima J Med Sci, 2015, 61(2):111-124. doi: 10.5387/fms.2015-11
[17]	Karantanos T, Theodoropoulos G, Gazouli M, et al. Expression of clock genes in patients with colorectal cancer[J]. Int J Biol Markers, 2013, 28 (3):280-285. doi: 10.5301/JBM.5000033
[18]	Okazaki F, Matsunaga N, Okazaki H, et al. Circadian clock in a mouse colon tumor regulates intracellular iron levels to promote tumor progression[J]. J Biol Chem, 2016, 291(13):7017-7028. doi: 10.1074/jbc.M115.713412
[19]	Jiang WL, Zhao SL, Jiang XH, et al. The circadian clock gene bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway[J]. Cancer Leu, 2016, 371(2):314-325. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=a42efcdcf188e0d667f8a69c381cd304
[20]	Taniguchi H, Fernandez AF, Setien F, et al. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies[J]. Cancer Res, 2009, 69(21):8447-8454. doi: 10.1158/0008-5472.CAN-09-0551
[21]	Yang MY, Yang WC, Lin PM, et al. Altered expression of circadian clock genes in human chronic myeloid leukemia[J]. J Bio Rhythms, 2011, 26 (2):136-148. doi: 10.1177/0748730410395527
[22]	Rana S, Munawar M, Shahid A, et al. Deregulated wxpression of circadian clock and clock- controlled cell cycle genes in chronic lymphocytic leukemia[J]. Mol Biol Rep, 2014, 41(1):95-103. doi: 10.1007/s11033-013-2841-7
[23]	Tiphaine M, Patrick M, Frederic T, et al. Circadian clock characteristics are altered in human thyroid malignant nodules[J]. J Clin Endocrinol Metab, 2013, 98(11):4446-4456. doi: 10.1210/jc.2013-2568
[24]	杨福全, 王泽平, 王鑫, 等.生物钟基因Clock、Bmal1蛋白在胆管癌组织中的表达及临床意义[J].中国现代普通外科进展, 2014, 17(2):108- 111. http://d.old.wanfangdata.com.cn/Periodical/zgxdptwkjz201402007
[25]	Hu ML, Yeh KT, Lin PM, et al. Deregulated expression of circadian clock genes in gastric cancer[J]. BMC Gastroenterol, 2014, 14(1):2-17. doi: 10.1186/1471-230X-14-2
[26]	宋俊梅, 邹文萍, 胡欣, 等.节律基因hClock及hBmall对胃癌化疗敏感性的影响[J].中国肿瘤临床, 2013, 40(20):1213-1216. doi: 10.3969/j.issn.1000-8179.20130509
[27]	Li XM, Mohammad- Djafari A, Dumitru M, et al. A circadian clock transcription model for the personalization of cancer chronotherapy [J]. Cancer Res, 2013, 73(24):7176-7188. doi: 10.1158/0008-5472.CAN-13-1528
[28]	Zeng ZL, Luo HY, Yang J, et al. Overexpression of the circadian clock gene bmall increases sensitivity to oxaliplatin in colorectal cancer[J]. Clin Cancer Res, 2014, 20(4):1042-1052. doi: 10.1158/1078-0432.CCR-13-0171
[29]	Slat EA, Sponagel J, Marpegan L, et al. Cell-intrinsic, Bmal1-dependent circadian regulation of temozolomide sensitivity in glioblastoma[J]. Biol Rhythms, 2017, 21(2):121-129. http://cn.bing.com/academic/profile?id=5a7fe4a0e57b5663402208c7d59fe91e&encoded=0&v=paper_preview&mkt=zh-cn
[30]	Xiong J, Li GM. Reserach advances of circadian clock genes and chronnotherapy[J]. Modern Oncology, 2013, 21(11):2622-2625. http://en.cnki.com.cn/Article_en/CJFDTOTAL-SXZL201311079.htm
[31]	金风, 欧阳金陵, 董红敏, 等.鼻咽癌DDP+5-FU/CF方案时辰化疗的临床前瞻性随机研究[J].中国肿瘤临床, 2004, 31(19):50-52. http://www.cjco.cn/CN/abstract/abstract11673.shtml
[32]	毕婷, 金风, 吴伟莉, 等.诱导化疗不同给药方式治疗鼻咽癌的Ⅱ期临床研究[J].中华肿瘤杂志, 2015, 37(9):676-681. doi: 10.3760/cma.j.issn.0253-3766.2015.09.010
[33]	毛振华, 金风, 吴伟莉, 等.时辰化疗治疗初治远处转移鼻咽癌的临床研究[J].中国肿瘤临床, 2015, 42(14):709-715. http://www.cjco.cn/CN/abstract/abstract11293.shtml
[34]	李卓玲, 金风, 吴伟莉, 等.诱导化疗加同步时辰化疗联合调强放射治疗局部晚期鼻咽癌的前瞻性随机对照研究[J].中华放射医学与防护杂志, 2015, 35(7):505-509. doi: 10.3760/cma.j.issn.0254-5098.2015.07.006
[35]	罗秀玲, 金风, 毕婷, 等.TPF方案诱导化疗不同给药方式联合调强放疗治疗局部晚期鼻咽癌的中期疗效及预后分析[J].中华放射医学与防护杂志, 2018, 38(8):595-601. doi: 10.3760/cma.j.issn.0254-5098.2018.08.007
[36]	靳骏腾, 金风, 李媛媛, 等.时辰化疗联合调强放疗对局部晚期鼻咽癌患者生命质量和营养状况的影响[J].中国癌症防治杂志, 2017, 9 (4):289-294. doi: 10.3969/j.issn.1674-5671.2017.04.09
[37]	Zhang PX, Jin F, Li ZL, et al. A randomized phase Ⅱ trial of induction chemotherapy followed by cisplatin chronotherapy versus constant rate delivery combined with radiotherapy[J]. Chronobiol Int, 2018, 35(2):240-248. doi: 10.1080/07420528.2017.1397684
[38]	万山, 金风, 吴伟莉, 等.两种不同给药速度的时辰化疗联合调强放疗治疗局部晚期鼻咽癌的临床研究[J].中华放射医学与防护杂志, 2018, 38(4):278-284. doi: 10.3760/cma.j.issn.0254-5098.2018.04.007
[39]	Bjarnason GA, Mackenzie RG, Nabid A, et al. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: A prospective randomized trial of the national cancer institute of Canada Clinical Trials Group (HN3)[J]. Int J Radiat Oncol Biol Phys, 2009, 73(1):166-172. doi: 10.1016/j.ijrobp.2008.07.009
[40]	Zhang Y, Chen X, Ren P, et al. Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2013, 87(2): 356-362. doi: 10.1016/j.ijrobp.2013.05.047
[41]	何丽佳, 吴敬波.拓扑替康不同时间给药对人鼻咽癌细胞放射增敏作用的实验研究[J].临床肿瘤学, 2010, 15(6):511-513. doi: 10.3969/j.issn.1009-0460.2010.06.007
[42]	Georg AB, Robert GM, Abdenour N, et al. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the national cancer institute of Canada clinical trials group (HN3)[J]. Int J Radiat Oncol Biol Phys, 2009, 73(1):166-172. doi: 10.1016/j.ijrobp.2008.07.009
[43]	史玉树.局部晚期非小细胞肺癌时辰放疗的临床研究[J].中国实用医学, 2012, 7(26):100-101. http://d.old.wanfangdata.com.cn/Periodical/zgsyyy201226068
[44]	Heidi L, Ewen C. Circadian clocks scoop Nobel prize[J]. Nature, 2017, 10(550):18. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=f9553d2c0cd24bc35ca31a73e0eafb43